Crosspoint Capital Strategies’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-1,052
Closed -$70.5K – 18
2017
Q4
$70.5K Hold
1,052
– – 0.06% 46
2017
Q3
$66K Buy
+1,052
New +$67.9K 0.05% 51
2016
Q1
– Sell
-200
Closed -$11K – 201
2015
Q4
$11K Buy
200
+134
+203% +$7.68K ﹤0.01% 684
2015
Q3
$4K Buy
+66
New +$3.66K ﹤0.01% 529
2015
Q1
– Sell
-1,974
Closed -$106K – 537
2014
Q4
$106K Buy
1,974
+8
+0.4% +$450 0.04% 282
2014
Q3
$111K Buy
1,966
+100
+5% +$5.91K 0.08% 147
2014
Q2
$112K Buy
1,866
+92
+5% +$5.39K 0.04% 176
2014
Q1
$99K Hold
1,774
– – 0.04% 186
2013
Q4
$97K Buy
+1,774
New +$94.4K 0.03% 195

Other funds holding BTI

Crosspoint Capital Strategies's BTI Position: Q1 2018 in Review

Crosspoint Capital Strategies sold out of British American Tobacco (BTI) in Q1 2018, closing a stake of 1,052 shares — an estimated $70.5K sold.

Crosspoint Capital Strategies first reported a position in BTI in Q4 2013 and held it in 9 quarters. The position peaked at $112K in Q2 2014. 577 funds tracked by Wall St. Rank hold BTI as of Q1 2018.

  • Crosspoint Capital Strategies reported no remaining British American Tobacco position as of Q1 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 1,052 British American Tobacco shares in Q1 2018, an estimated $70.5K.
  • Crosspoint Capital Strategies first reported a position in British American Tobacco in Q4 2013 and held it in 9 quarters.
  • Crosspoint Capital Strategies's British American Tobacco position peaked at $112K in Q2 2014.
  • 577 funds tracked by Wall St. Rank held British American Tobacco as of Q1 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2018, filed 14 May 2018.